NCT03910192: AF

Mindfulness to Reduce Ambulatory Hypertension in Atrial Fibrillation

Status unknown NA Last updated 10 April 2019

What this trial tests

NA trial testing Mindfulness-based coaching in Atrial Fibrillation in 50 participants. Status unknown.

Timeline

14 March 2017

Primary endpoint
31 August 2019

31 December 2019

Quick facts

Lead sponsor	York University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	14 March 2017
Primary completion	31 August 2019
Estimated completion	31 December 2019
Sites	1 location across Canada

Drugs / interventions tested

• Mindfulness-based coaching
• Dietary cardiovascular risk reduction coaching

Conditions studied

• Atrial Fibrillation — all drugs for Atrial Fibrillation →
• Hypertension — all drugs for Hypertension →
• Mindfulness — all drugs for Mindfulness →
• Cardiovascular Risk Reduction — all drugs for Cardiovascular Risk Reduction →

Sponsor

York University

Who can join

Adults 50 to 80, any sex, with Atrial Fibrillation or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effectiveness of a 16 week mindfulness-based coaching program compared to a cardiovascular risk reduction education program.

Both groups will undergo 24-hour ambulatory blood pressure monitoring, along with assessments of psychological measures (see bellow) at study baseline, midpoint (8 weeks), and conclusion (16 weeks).

In addition, both groups will also undergo 24-hour Holter monitoring assessments at study beginning and conclusion to assess possible episodes of atrial tachyarrhythmia during the assessed interval.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.